Newmont Corp SEC Filings

On July 1, 2025, SeaStar Medical Holding Corporation (ICU) Chief Medical Officer Kevin Chung filed a Form 4 disclosing the vesting and conversion of 5,000 restricted stock units (RSUs) into common shares. The transaction was coded “M,” signifying a conversion of derivative equity awards rather than an open-market purchase, and carried a price of $0 per share.

After the transaction, Dr. Chung now directly owns 48,184 ICU shares. This figure incorporates 25,000 shares that were previously reported as unvested RSUs in Table II and have been moved to Table I. The filing also corrects a prior one-share rounding error, and no derivative RSUs remain reportable from this grant.

The RSUs originated from a November 15, 2024 grant of 15,000 units that vest in three equal annual tranches beginning July 1, 2024; the current filing reflects the first installment. Because the shares were received under a pre-arranged compensation plan at no cost, the event does not inject new capital into the company nor constitute an open-market confidence signal. Nevertheless, it modestly increases insider equity alignment and provides transparency regarding executive compensation.

Amendment No. 5 to Schedule 13D discloses that the Silver Lake–affiliated reporting persons (Global Blue Holding L.P., SL Globetrotter L.P., SL Globetrotter GP Ltd., Silver Lake Technology Associates III Cayman L.P. and Silver Lake (Offshore) AIV GP III Ltd.) have tendered all of their equity interests in Global Blue Group Holding AG (“GB”) in connection with the cash tender offer launched by Shift4 Payments, Inc. and its Swiss merger subsidiary.

The offer, which commenced on 21 March 2025 and expired one minute after 11:59 p.m. (NYC time) on 2 July 2025, met all conditions. The Silver Lake vehicles tendered:

• 34,871,499 ordinary shares held by Cayman Holdings at $7.50 per share
• 4,939,137 Series A preferred shares (convertible into ordinary shares) at $10.00 per share
• 91,230,811 ordinary shares held by Globetrotter at $7.50 per share
• 11,970,487 Series A preferred shares held by Globetrotter at $10.00 per share

In addition, 2,701,935 Global Blue warrants (Cayman Holdings) and 6,548,415 warrants (Globetrotter) were cashed-out and are no longer exercisable. As a result of these transactions, the reporting persons now report 0 shares beneficially owned (0.0% of the class) and thereby cease to be 5% holders as of 3 July 2025.

Following completion of the offer, director Joseph Osnoss resigned from the Global Blue board. The filing attaches an amended Annex A listing directors of the Silver Lake general partners and adds Exhibit 99.1 containing that information.

This amendment is limited to updating ownership, identity disclosures and purpose-of-transaction details; all other information in prior filings remains unchanged.

Form 4 Overview – Appian Corporation (APPN)

Director Albert G.W. Biddle III reported a routine equity award on 1 July 2025. The filing shows:

• 1,046 Class A shares acquired at $0 pursuant to Appian’s 2017 Equity Incentive Plan and the Non-Employee Director Compensation Policy.
• Post-transaction ownership rises to 31,478 directly held shares.
• Mr. Biddle also controls several family trusts and a corporate entity, bringing his total indirect holdings to 128,937 shares (15,479 shares in each of three trusts and 82,500 shares through Jack Biddle Inc.).

No sales or derivative transactions were disclosed, and no options or warrants were exercised. The grant represents a ~0.65 % increase in Mr. Biddle’s aggregate beneficial ownership (now approximately 160,415 shares).

This appears to be a standard, non-market purchase for board compensation rather than a signal of strategic intent or a change in insider sentiment. The transaction is not likely to have a material impact on Appian’s share float or valuation.

Newmont Corporation (NEM) – Form 144 filing: Insider Peter I. Toth has notified the SEC of his intent to sell 3,000 common shares on or about 01 Jul 2025 through Fidelity Brokerage Services on the NYSE. The proposed sale has an estimated market value of $176,250, versus the company’s outstanding share count of 1,112,996,934; the transaction therefore represents roughly 0.0003 % of shares outstanding.

The shares were acquired via restricted-stock vesting on 27 Jul 2024 and are being sold for the account of Mr. Toth. He attests that he possesses no undisclosed material adverse information. Under Rule 144, the filer also discloses a recent selling pattern: in the past three months Mr. Toth sold 9,000 shares (3,000 each on 01 Apr, 01 May, and 02 Jun 2025) for total gross proceeds of $462,090.

The filing signals continued insider disposals but the absolute volume is immaterial relative to Newmont’s float. Nevertheless, investors often monitor repetitive insider sales for sentiment cues. No financial performance metrics, earnings data, or corporate strategic information are included in this notice.